KG, yes many institutions, especially the large firms, do consider $5.00 to ba a minimum as I understand. Some of the moderate to smaller firms have a $1.00 minimum as I also understand it. As far as your other questions, you need to do your own Due Diligence on HQNT and draw your own conclusions.
Personally, I am most intrigued with the information on their new product, LabQuotient, and $5M profit projections for it mentioned in a recent press release (see PR below). With about 25M shares O/S, one can do the math on what the EPS gain would be IF that were to come true.
I was also impressed that Dr. Laipply has accumulated 1M shares, and that both he and Larry Burden, a former Senior VP at Freddie Mac, joined the H-Quotient team. Surely they checked out the company pretty thoroughly and did they own Due Diligence before agreeing to become involved, I reasoned. But any investment carries potential reward and risk and that is where each must decide for themselves. We each must decipher the reward and risk potential. All I am doing is supplying some DD links to help anyone that is interested to get started. Whether the stock price of the Company goes up soon or not, whether it bases here for a while longer, goes back down a little, or up to old highs near $7 in the next year or two is anyone's educated guess.
SOME DUE DILIGENCE:
YAHOO INFO:
finance.yahoo.com
CHART:
bigcharts.marketwatch.com.
COMPANY WEBSITE: h-quotient.com
RECENT DEVELOPMENTS
** Announced $5M projected Net for LabQuotient (see PR below) This would dramatically increase revenues by 300% or more, so worth noting.
** Added two very high quality team members recently (who presumably did their own DD on the company)
(1) Dr. Thomas Laipply, Dir. of Molecular Tissue Pathology, Nichols Institute at Quest Diagnostics (see recent P.R. below) and share purchases on the open market.
(2) Laurence Burden, V.P. of Operations to help market HQNT’s medical software products. Look at his resume (from recent PR below)
- "As corporate VP and Chief Information Officer (CIO) and member of the turnaround team, he helped make possible the $2.3 billion sale of Firestone to Bridgestone" Also, "As Senior VP and CIO of Freddie Mac, he redesigned its computer systems and financial engineering systems, providing the basis for hundreds of millions in revenues and savings."
OTHER INFO
** Very little debt (about $200K per CEO) unlike most penny stocks
** Shares O/S = 25M (12M float – 4M “true float” – per CEO)
** Good history of stock success at much higher prices, yet fundamentals probably stronger than ever (but that’s for you to decide)
FILING INFO AND RECENT NEWS:
Please verify yourself these and other figures below by looking at the current filings at freedgar.com and especially the new filing when it comes out.
QUICK INFO
** Shares O/S = 25M approx.(per CEO - old filing will state a bit less)
** True Float = about 4M (another 8M tightly held, I’m told) by the CEO, making 12M)
Two year high/low (approx): $7+ to about .16
RECENT PRESS RELEASES
H-Quotient, Inc., Announces LabQuotient; $5 Million Net Projected
VIENNA, Va., Mar 25, 2002 /PRNewswire-FirstCall via COMTEX/ -- H-Quotient, Inc., (OTC Bulletin Board: HQNT chart, msgs) and Dr. Thomas C. Laipply, MD, FCAP, FIAP, Director of Molecular Tissue Pathology, Nichols Institute at Quest Diagnostics announced LabQuotient, a relational database for improving and monitoring medical test ordering. The product is expected to be ready for market this summer. Pre-production orders have been received. Further details will be announced in a subsequent release.
H-Quotient, Inc., is projected to earn net income of $5 million in the product's first year. All income will be recurring and is expected to grow substantially because the universe for this revolutionary product includes clinical doctors, dentists, veterinarians, emergency rooms, urgent care centers, insurance companies, HMOs, hospital quality assurance personnel, commercial laboratories, and pharmaceutical-drug companies.
****
H-Quotient, Inc., Announces Appointment of Laurence T. Burden As V.P. of Operations ---- Check his resume:
siliconinvestor.com
****
H-Quotient, Inc., Announces More Than 1 Million Shares Purchased by Dr. Laipply
siliconinvestor.com
****
H-Quotient, Inc. Announces LabQuotient Prototype; Full-Scale Sales Effort to Commence
siliconinvestor.com
****
H-Quotient, Inc., Announces Development of Blood Utilization Software
siliconinvestor.com
****
OTHER NEWS
siliconinvestor.com
Do your own DD. You may want to call Doug Kohn, the CEO, at 703-821-3434
Disclaimer
I am likely being compensated by the Company to help bring some honest exposure to it and try to attract longer term shareholders who beleive in its potential after doing their own Due Diligence. I have entered into a verbal agreement to be paid 15k shares of 1 year restricted stock (meaning I cannot sell it until at least April 2003). Some will not want to buy HQNT because of that and that is their right. However, it could be stated that those who do receive compensation, if they are smart, are usually much more careful about being honest than those who are not. Why? Because they are easy targets for prosecution by the SEC should they purposely lie or "pump and dump". I will also state that I have not been paid any shares yet by the Company, and again, as I said will not be able to sell them for a year after I do.
Good luck, whatever you decide to do. I will keep supplying information from time to time and if anyone PM's me, I will be happy to add them to a mailing list. I hope many will keep an open mind and consider my integrity and Forbe Magazine award and check out this company as a longer term holding.
thanks,
Dave (Bob)
PS- Please be assured that unlike most on SI who never say anything about receieving compensation from companies, I will always be upfront about it and state it publicly immediately, should it happen in the future. |
